NorthCrest Asset Manangement LLC Buys 2,967 Shares of Axon Enterprise, Inc $AXON

NorthCrest Asset Manangement LLC increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 947.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,280 shares of the biotechnology company’s stock after purchasing an additional 2,967 shares during the quarter. NorthCrest Asset Manangement LLC’s holdings in Axon Enterprise were worth $1,939,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AXON. Stone House Investment Management LLC bought a new position in Axon Enterprise in the 3rd quarter worth about $29,000. New Millennium Group LLC purchased a new position in Axon Enterprise during the 3rd quarter valued at about $29,000. Root Financial Partners LLC bought a new stake in shares of Axon Enterprise during the third quarter valued at about $34,000. Darwin Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the second quarter worth about $37,000. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Axon Enterprise in the second quarter worth about $56,000. 79.08% of the stock is currently owned by institutional investors.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Market action: AXON closed higher in the most recent session, reflecting short‑term buying interest. Axon Enterprise (AXON) Surpasses Market Returns
• Positive Sentiment: Contract extension: Batavia extended a contract for police body‑camera data storage — a direct revenue/support win for Axon’s cloud evidence/storage business. This reinforces recurring‑revenue visibility from municipal customers. Batavia City Council OKs contract extension for police body camera data storage
• Positive Sentiment: Defense spending narrative: A commentary piece highlights Axon as a top defense/ public‑safety pick amid a large federal spending push, supporting the thesis that defense/first‑responder budgets could be a multi‑year growth tailwind. Hegseth Says It ‘Takes Money to Kill Bad Guys’…
• Positive Sentiment: New local adoption: Syracuse selected Axon as its license‑plate‑reader provider — another municipal win that supports product adoption across public‑safety portfolios. What to know about Axon, Syracuse’s newest license plate reader provider
• Positive Sentiment: Analyst/investor praise: Several investing write‑ups (including The Motley Fool and InsiderMonkeys summaries) continue to highlight Axon’s AI + hardware + subscription model as a high‑growth thesis. These narratives can support multiple expansion if execution stays strong. 2 Tech Stocks That Could Help Make You a Fortune
• Positive Sentiment: Institutional interest note: A recent investor letter/profile highlights Axon as an attractive mid‑cap growth opportunity, signaling continued institutional attention. What Makes Axon (AXON) an Attractive Opportunity?
• Neutral Sentiment: Comparative coverage: A sector comparison piece contrasts Axon with CAE; useful for valuation context but not an immediate catalyst. Contrasting Axon Enterprise and CAE
• Neutral Sentiment: Name confusion alert: AppLovin is expanding a product called “Axon AI” — this is unrelated to Axon Enterprise but can cause headlines/keyword noise; not a company catalyst. AppLovin Expands Axon AI As Investors Weigh Broader Growth Potential
• Neutral Sentiment: Short‑interest data shown for March is effectively blank/inconclusive (reported zeros); no reliable signal on bearish positioning from that data point.
• Negative Sentiment: Insider sale: A director sold ~$77k of stock — a small, single‑sale that could raise mild governance questions but is not large enough alone to indicate a change in company fundamentals. Insider Selling: Axon Enterprise Director Sells Stock
• Negative Sentiment: Local scrutiny: Opinion pieces and calls for mayoral discussion (e.g., Denver) underscore continuing political/community scrutiny over Axon contracts — a recurring risk for municipal renewals and reputation. Mike Johnston Says He’s Listening, but Will He Meet With Constituents?

Insider Activity

In other news, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total transaction of $860,175.00. Following the sale, the chief accounting officer owned 12,240 shares in the company, valued at approximately $7,019,028. This trade represents a 10.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the sale, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. This represents a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 23,855 shares of company stock worth $13,299,928. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Up 2.2%

Shares of NASDAQ AXON opened at $507.28 on Tuesday. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The business has a 50-day moving average of $516.98 and a 200-day moving average of $597.88. The firm has a market capitalization of $40.79 billion, a price-to-earnings ratio of 333.74, a PEG ratio of 10.59 and a beta of 1.46. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. During the same period last year, the firm posted $2.08 earnings per share. Axon Enterprise’s quarterly revenue was up 38.5% on a year-over-year basis. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. Northcoast Research upgraded shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price on the stock in a research note on Tuesday, January 6th. UBS Group cut their price target on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a report on Wednesday, February 25th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Finally, Needham & Company LLC decreased their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $762.93.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.